As of 2024-12-14, the EV/EBITDA ratio of Devyser Diagnostics AB (DVYSR.ST) is -35.88. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. DVYSR.ST's latest enterprise value is 1,887.51 mil SEK. DVYSR.ST's TTM EBITDA according to its financial statements is -52.60 mil SEK. Dividing these 2 quantities gives us the above DVYSR.ST EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 5.4x - 8.0x | 6.7x |
| Forward P/E multiples | 6.2x - 9.4x | 7.8x |
| Fair Price | (13.21) - (18.94) | (16.42) |
| Upside | -110.9% - -115.7% | -113.6% |
| Date | EV/EBITDA |
| 2024-12-13 | -35.88 |
| 2024-12-12 | -35.73 |
| 2024-12-11 | -36.20 |
| 2024-12-10 | -36.20 |
| 2024-12-09 | -36.20 |
| 2024-12-06 | -36.83 |
| 2024-12-05 | -36.67 |
| 2024-12-04 | -36.51 |
| 2024-12-03 | -36.98 |
| 2024-12-02 | -38.40 |
| 2024-11-29 | -38.71 |
| 2024-11-28 | -39.34 |
| 2024-11-27 | -39.49 |
| 2024-11-26 | -40.59 |
| 2024-11-25 | -40.12 |
| 2024-11-22 | -38.40 |
| 2024-11-21 | -39.18 |
| 2024-11-20 | -39.65 |
| 2024-11-19 | -39.34 |
| 2024-11-18 | -39.34 |
| 2024-11-15 | -39.34 |
| 2024-11-14 | -40.59 |
| 2024-11-13 | -39.65 |
| 2024-11-12 | -41.22 |
| 2024-11-11 | -41.53 |
| 2024-11-08 | -40.59 |
| 2024-11-07 | -41.06 |
| 2024-11-06 | -40.28 |
| 2024-11-05 | -40.12 |
| 2024-11-04 | -40.12 |
| 2024-11-01 | -41.38 |
| 2024-10-31 | -38.08 |
| 2024-10-30 | -38.87 |
| 2024-10-29 | -39.49 |
| 2024-10-28 | -37.77 |
| 2024-10-25 | -37.92 |
| 2024-10-24 | -38.08 |
| 2024-10-23 | -39.02 |
| 2024-10-22 | -38.40 |
| 2024-10-21 | -38.24 |
| 2024-10-18 | -38.87 |
| 2024-10-17 | -38.55 |
| 2024-10-16 | -38.24 |
| 2024-10-15 | -38.40 |
| 2024-10-14 | -39.02 |
| 2024-10-11 | -39.49 |
| 2024-10-10 | -39.18 |
| 2024-10-09 | -40.28 |
| 2024-10-08 | -40.59 |
| 2024-10-07 | -39.02 |